C-reactive protein in acute myocardial infarction: Association with heart failure

American Heart Journal

Volumn 145, Issue 6, 2003, Pages 1094-1101

  Berton, Giuseppe ^a   Cordiano, Rocco ^b   Palmieri, Rosa ^b   Pianca, Sigismondo ^a   Pagliara, Valeria ^a   Palatini, Paolo ^c,d  

^a Department of Cardiology   (Italy)

^b Adria General Hospital   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Clinica Medica V   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HEART INFARCTION; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; STATISTICS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STATISTICS; STROKE VOLUME;

EID: 0037606191     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00098-X     Document Type: Article

References (26)

1. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
2. Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-6.
3. Ferreiros ER, Boissonnet CP, Pizarro R, et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999;100:1958-63.
4. Tomoda H, Aoki N. Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J 2000;140:324-8.
5. Tommasi S, Carluccio E, Bentivoglio M, et al. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol 1999;83:1595-9.
6. Nikfardjam M, Mullner M, Schreiber W, et al. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med 2000;247:341-5.
7. Nicod P, Gilpin E, Dittrich H, et al. Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol 1988;61:1165-71.
8. Emanuelsson H, Karlson BW, Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J 1994;15:761-8.
9. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
10. Stevenson R, Ranjadayalan K, Wilkinson P, et al. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ 1993;307:349-53.
11. Berger AK, Breall JA, Gersh BJ, et al. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project). Am J Cardiol 2001;87:272-7.
12. Ali AS, Rybicki BA, Alam M, et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J 1999;138:1133-9.
13. Pietila KO, Harmoinen AP, Jokiniitly J, et al. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 1996;17:1345-9.
14. Aukrust P, Gullestad L, Lappegard KT, et al. Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment. Circulation 2001;104:1494-500.
15. Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999;83:376-82.
16. Pasternak RC, Braunwald E, Sobel BE. Acute myocardial infarction. In: Braunwald E, editor. Heart disease. 5th ed. Philadelphia: WB Saunders; 1997. p. 1198-207.
17. Stemberg JC. A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem 1997;23:1456-60.
18. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967;20:457-64.
19. Erbel R. Comparison of single-plane and biplane volume determination by two-dimensional echocardiography: 1. Asymmetric model hearts. Eur Heart J 1982;3:469-74.
20. Altman DG. Modelling survival, the Cox regression model. In: Altman DG, editor. Practical statistics for medical research. London: Chapman & Hall; 1992. p. 387-94.
21. Mariotti R, Musumeci G, De Carlo M, et al. Acute-phase reactants in acute myocardial infarction: impact on 5-year prognosis. Ital Heart J 2001;2:294-300.
22. Rabbani LE. Acute coronary syndromes: beyond myocyte necrosis. N Engl J Med 2001;345:1057-9.
23. Beranek JT. C-reactive protein and complement in myocardial infarction and postinfarction heart failure. Eur Heart J 1997;18:1834-6.
24. Lagrand WK, Niessen HW, Wolbink GJ, et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997;95:97-103.
25. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
26. de Beer FC, Hind CR, Fox KM, et al. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982;47:239-43.